Aluminum is poorly absorbed following either oral or inhalation exposure and is essentially not absorbed dermally. The bioavailability of aluminum is strongly influenced by the aluminum compound and the presence of dietary constituents which can complex with aluminum and enhance or inhibit its absorption. Aluminum binds to various ligands in the blood and distributes to every organ, with highest concentrations found in bone and lung tissues. In living organisms, aluminum is believed to exist in four different forms: as free ions, as low-molecular-weight complexes, as physically bound macromolecular complexes, and as covalently bound macromolecular complexes. Absorbed aluminum is excreted principally in the urine and, to a lesser extent, in the bile, while unabsorbed aluminum is excreted in the faeces. (L739)
The main target organs of aluminum are the central nervous system and bone. Aluminum binds with dietary phosphorus and impairs gastrointestinal absorption of phosphorus. The decreased phosphate body burden results in osteomalacia (softening of the bones due to defective bone mineralization) and rickets. Aluminum's neurotoxicity is believed to involve several mechanisms. Changes in cytoskeletal protein functions as a results of altered phosphorylation, proteolysis, transport, and synthesis are believed to be one cause. Aluminum may induce neurobehavioral effects by affecting permeability of the blood-brain barrier, cholinergic activity, signal transduction pathways, lipid peroxidation, and impair neuronal glutamate nitric oxide-cyclic GMP pathway, as well as interfere with metabolism of essential trace elements because of similar coordination chemistries and consequent competitive interactions. It has been suggested that aluminum's interaction with estrogen receptors increases the expression of estrogen-related genes and thereby contributes to the progression of breast cancer (A235), but studies have not been able to establish a clear link between aluminum and increased risk of breast cancer (A15468). Certain aluminum salts induce immune responses by activating inflammasomes. (L739, A235, A236)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
致癌性证据
A4:无法归类为人类致癌物。/铝金属和难溶化合物/
A4: Not classifiable as a human carcinogen. /Aluminum metal and insoluble compounds/
Not listed by IARC. IARC classified aluminum production as carcinogenic to humans (Group 1), but did not implicate aluminum itself as a human carcinogen. (L135) A link between use of aluminum-containing antiperspirants and increased risk of breast cancer has been proposed (A235), but studies have not been able to establish a clear link (A15468).
Aluminum targets the nervous system and causes decreased nervous system performance and is associated with altered function of the blood-brain barrier. The accumulation of aluminum in the body may cause bone or brain diseases. High levels of aluminum have been linked to Alzheimer's disease. A small percentage of people are allergic to aluminium and experience contact dermatitis, digestive disorders, vomiting or other symptoms upon contact or ingestion of products containing aluminium. (L739, L740)
The degree of aluminum absorption depends on a number of factors, such as the aluminum salt ingested, pH (for aluminum speciation and solubility), bioavailability, as well as dietary conditions. These facts should be taken into consideration during tissue dosimetry and response assessment to aluminum sulfate. It can be concluded that the use of currently available animal studies to develop a guideline value is inappropriate at this time due to the above specific toxicokinetic/dynamic factors that may affect results.
来源:DrugBank
吸收、分配和排泄
消除途径
铝主要通过肾脏排出,因此在肾功能衰竭的患者中可能会积累。大约2%通过胆汁排出。
Aluminum is excreted predominantly via the kidneys and therefore may accumulate in patients with renal failure. About 2% is excreted in bile.
来源:DrugBank
吸收、分配和排泄
分布容积
被吸收的铝主要位于心脏、脾脏和骨骼中。
Aluminium which is absorbed is located primarily in the heart, spleen, and bone.
In mammals GI absorption of ingested aluminum is poor due to transformation of aluminum salts into insoluble aluminum phosphate (AlPO4) in digestive tract, brought about by pH changes and presence of phosphate in diet. At higher doses, such as 200 mg aluminum/kg as aluminum sulfate, intestinal absorption is about 10% in rats ... .
... No increases in urinary excretion of aluminum or in aluminum deposition in organs of rats when twice normal aluminum concentration was given as ... sulfate in food. When concentration was increased to about 15 times normal, both urinary excretion and organ deposition were enhanced.
Solid catalyst components for olefin polemerization and use thereof
申请人:Nippon Oil Company, Limited
公开号:US05604170A1
公开(公告)日:1997-02-18
An effective catalyst carrier for use in the polymerization of olefins is provided. Said carrier comprises particles of silicon oxide or aluminum oxide satisfying the following characteristics (A) to (E): (A) An average particle diameter as measured by the sieving method is in the range of 20 to 150 .mu.m. (B) A specific surface area as measured by the BET method is in the range of 150 to 600 m.sup.2 /g. (C) The volume of pores ranging in pore radius from 18 to 1,000 Angstroms as measured by the mercury penetration method is in the range of 0.3 to 2.0 cm.sup.3 /g. (D) An apparent specific gravity as measured according to JIS K6220-6.8 is not lower than 0.32. (E) After the particles classified in the range of between 53 .mu.m and 75 .mu.m by the sieving method have been subjected to an ultrasonic disintegration treatment at 40 KHz, 35 W, for 20 minutes, the proportion of 50 .mu.m or smaller particles, i.e., degree of ultrasonic disintegration, is not more than 30%.
Method of preparing a controlled pore volume alumina with citric acid
申请人:Nalco Chemical Company
公开号:US04179411A1
公开(公告)日:1979-12-18
A method for preparing an alumina having controlled pore volume distribution is disclosed. The method requires the presence of 0.1-15% by weight of a water soluble aliphatic polycarboxylic acid having from 2-12 carbon atoms based on the dry weight of Al.sub.2 O.sub.3, during alumina precipitation. The resultant calcined alumina has a pore volume distribution such that: A. Nitrogen desorption measurements indicate that less than 10% of the total pores as determined by said method fall between 100-1200A in diameter; B. Nitrogen adsorption measurements indicate that between 10-50% of the total pore volume as determined fall between 100-1200A in diameter; and C. Mercury penetration porisimetry indicates that less than 10% of the total pores as determined by both nitrogen desorption and mercury methods fall between 100-50,000A in diameter.
Process for reclaiming aluminum from waste paper and packaging products
申请人:——
公开号:US05456739A1
公开(公告)日:1995-10-10
Aluminum is recovered from organic waste paper and packaging material containing aluminum foil by heating the waste material in a kiln or other such device to decompose the organic constituents in the waste material, preferably by pyrolysis, producing hot gaseous by-products with a carbonaceous ash residue containing aluminum. The ash residue is contacted with an aqueous solution of sulfuric acid under conditions which cause the aluminum to react with the sulfuric acid to produce aluminum sulfate. Preferably, the ash/acid contacting is carried out with a relatively dilute sulfuric acid solution and at an elevated temperature in the range of from about 80.degree. C. to about 100.degree. C. to produce Al.sub.2 (SO.sub.4).sub.3.18H.sub.2 O as the reaction product.
A catalyst for purifying exhaust and waste gases comprising A. a support substrate comprising 2 to 100% by weight of an oxide complex of titanium and phosphorus containing titanium and phosphrus in such a proportion that the molar ratio of TiO.sub.2 to P.sub.2 O.sub.5 is from 5.0 to 0.5 and 98 to 0% by weight of aluminum oxide, and B. supported on said substrate as a catalytic substance, 2 to 300 parts by weight, calculated as metal oxide per 100 parts by weight of the support substrate (A), of at least one heavy metal selected from the group consisting of Ni, Cu, Cr, Fe, Co, Mn, Bi, V, W, Mo, Sn, Zn, Zr, Pb, Sb, Ti, Ta, Cd and Nb, or 0.01 to 1.0 part by weight, calculated as metal per 100 parts by weight of the support substrate (A), of at least one noble metal selected from the group consisting of Pt, Pd, Rh, Ir, Os and Ru.
Shale-stabilizing drilling fluids and method for producing same
申请人:Sun Drilling Products Corporation
公开号:US04719021A1
公开(公告)日:1988-01-12
Shale-stabilizing drilling fluids for use in connection with subterranean well drilling operations. The drilling fluids contain polyvalent metal/guanidine complexes, especially aluminum/guanidine complexes, and preferably contain guanidinium ion and aluminate ion accompanied by (a) cationic starches and (b) a glycol selected from the group consisting of polybutylene glycol, polyethylene glycol, polypropylene glycol and mixtures thereof.